Showing results (301-310 of 399) with videos related to

Sort By:
Pageof 40
Leukemia|October 10, 1998
Combination of aclarubicin and etoposide for the treatment of advanced acute myeloid leukemia: results of a prospective multicenter phase II trial. German AML Cooperative GroupW Kern, J Braess, A Grote-Metke, et al.
Cancer Biology & Therapy|August 25, 2006
Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinomaDjordje Atanackovic, Inga Blum, Yanran Cao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2016
C1P Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Preventing NF-κB Activation in NeutrophilsKristin Baudiß, Rodolfo de Paula Vieira, Sanja Cicko, et al.
Genes, Chromosomes & Cancer|March 28, 2003
A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 geneEva Maria Murga Penas, Jan Cools, Petra Algenstaedt, et al.
Lung Cancer (Amsterdam, Netherlands)|July 5, 2005
Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC)Eckart Laack, Antje Scheffler, Iris Burkholder, et al.
Oncotarget|August 11, 2018
Extracellular ATP is a danger signal activating P2X7 receptor in a LPS mediated inflammation (ARDS/ALI)Sanja Cicko, Thomas Christian Köhler, Cemil Korcan Ayata, et al.
Leukemia|January 1, 1992
Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study GroupR Hehlmann, H Heimpel, M Griesshammer, et al.
Stem Cells and Development|May 25, 2007
Mobilization of putative high-proliferative-potential endothelial colony-forming cells during antihypertensive treatment in patients with essential hypertensionRalf A Benndorf, Ursula M Gehling, Daniel Appel, et al.
Medizinische Klinik (Munich, Germany : 1983)|August 15, 1997
[Transplantation of hematopoietic stem cells. I: Definitions, principle indications, complications]H Link, H J Kolb, W Ebell, et al.
Onkologie|February 1, 1991
[Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)]R Hehlmann, H Heimpel, B Heinze, et al.
Pageof 40